Annual SGA
$11.04 M
-$1.00 M-8.31%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual SGA is $11.04 million, with the most recent change of -$1.00 million (-8.31%) on September 30, 2024.
- During the last 3 years, AVXL annual SGA has risen by +$2.02 million (+22.41%).
- AVXL annual SGA is now -15.54% below its all-time high of $13.07 million, reached on September 30, 2022.
Performance
AVXL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.78 M
-$78.00 K-2.73%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly SGA is $2.78 million, with the most recent change of -$78.00 thousand (-2.73%) on September 30, 2024.
- Over the past year, AVXL quarterly SGA has dropped by -$78.00 thousand (-2.73%).
- AVXL quarterly SGA is now -28.74% below its all-time high of $3.90 million, reached on September 30, 2022.
Performance
AVXL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.27 B
-$43.00 M-3.49%
September 30, 2024
Summary
- As of February 7, 2025, AVXL TTM SGA is -$1.27 billion, with the most recent change of -$43.00 million (-3.49%) on September 30, 2024.
- Over the past year, AVXL TTM SGA has dropped by -$1.29 billion (-11846.08%).
- AVXL TTM SGA is now -1202211.32% below its all-time high of -$106.00 thousand.
Performance
AVXL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AVXL Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -8.3% | -2.7% | -10000.0% |
3 y3 years | +22.4% | -3.4% | -10000.0% |
5 y5 years | +61.2% | -3.4% | -10000.0% |
AVXL Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -15.5% | +22.4% | -28.7% | +7.3% | -66.0% | at low |
5 y | 5-year | -15.5% | +88.5% | -28.7% | +105.7% | -140.9% | at low |
alltime | all time | -15.5% | -100.0% | -28.7% | -100.0% | <-9999.0% | at low |
Anavex Life Sciences Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | $11.04 M(-8.3%) | $2.78 M(-2.7%) | $11.04 M(+1.7%) |
Jun 2024 | - | $2.86 M(+2.5%) | $10.85 M(-3.5%) |
Mar 2024 | - | $2.79 M(+6.9%) | $11.24 M(-0.8%) |
Dec 2023 | - | $2.61 M(+0.7%) | $11.33 M(-5.9%) |
Sep 2023 | $12.04 M(-7.9%) | $2.59 M(-20.2%) | $12.04 M(-9.8%) |
Jun 2023 | - | $3.25 M(+12.7%) | $13.35 M(+0.5%) |
Mar 2023 | - | $2.88 M(-13.1%) | $13.29 M(-0.2%) |
Dec 2022 | - | $3.32 M(-15.0%) | $13.32 M(+1.9%) |
Sep 2022 | $13.07 M(+44.9%) | $3.90 M(+22.5%) | $13.07 M(+8.5%) |
Jun 2022 | - | $3.19 M(+9.3%) | $12.05 M(+6.7%) |
Mar 2022 | - | $2.92 M(-4.9%) | $11.30 M(+6.4%) |
Dec 2021 | - | $3.07 M(+6.5%) | $10.61 M(+17.7%) |
Sep 2021 | $9.02 M(+54.0%) | $2.88 M(+18.3%) | $9.02 M(+19.6%) |
Jun 2021 | - | $2.43 M(+9.0%) | $7.54 M(+16.2%) |
Mar 2021 | - | $2.23 M(+51.9%) | $6.49 M(+8.6%) |
Dec 2020 | - | $1.47 M(+4.8%) | $5.98 M(+2.0%) |
Sep 2020 | $5.86 M(-14.5%) | $1.40 M(+1.6%) | $5.86 M(-3.8%) |
Jun 2020 | - | $1.38 M(-19.7%) | $6.09 M(-0.1%) |
Mar 2020 | - | $1.72 M(+27.2%) | $6.10 M(-5.3%) |
Dec 2019 | - | $1.35 M(-17.3%) | $6.44 M(-6.0%) |
Sep 2019 | $6.85 M(+14.3%) | $1.64 M(+17.8%) | $6.85 M(+2.3%) |
Jun 2019 | - | $1.39 M(-32.6%) | $6.69 M(-3.3%) |
Mar 2019 | - | $2.06 M(+17.0%) | $6.92 M(+9.0%) |
Dec 2018 | - | $1.76 M(+18.9%) | $6.35 M(+6.1%) |
Sep 2018 | $5.99 M(+19.6%) | $1.48 M(-8.6%) | $5.99 M(+2.1%) |
Jun 2018 | - | $1.62 M(+8.8%) | $5.87 M(+3.8%) |
Mar 2018 | - | $1.49 M(+6.6%) | $5.65 M(+7.1%) |
Dec 2017 | - | $1.40 M(+2.7%) | $5.28 M(+5.4%) |
Sep 2017 | $5.01 M(-39.9%) | $1.36 M(-3.1%) | $5.01 M(-27.0%) |
Jun 2017 | - | $1.41 M(+25.9%) | $6.86 M(+4.1%) |
Mar 2017 | - | $1.12 M(-0.9%) | $6.59 M(+0.4%) |
Dec 2016 | - | $1.13 M(-65.0%) | $6.57 M(-25.5%) |
Sep 2016 | $8.33 M(+72.3%) | $3.22 M(+183.5%) | $8.81 M(-0.0%) |
Jun 2016 | - | $1.13 M(+4.1%) | $8.81 M(+5.0%) |
Mar 2016 | - | $1.09 M(-67.7%) | $8.39 M(+8.2%) |
Dec 2015 | - | $3.37 M(+4.6%) | $7.75 M(+60.3%) |
Sep 2015 | $4.84 M | $3.22 M(+351.3%) | $4.84 M(+153.0%) |
Jun 2015 | - | $713.50 K(+58.1%) | $1.91 M(-1.1%) |
Mar 2015 | - | $451.20 K(-0.2%) | $1.93 M(-18.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2014 | - | $452.10 K(+53.1%) | $2.38 M(+6.6%) |
Sep 2014 | $2.24 M(+19.4%) | $295.30 K(-59.8%) | $2.24 M(-32.5%) |
Jun 2014 | - | $733.80 K(-18.7%) | $3.31 M(+24.3%) |
Mar 2014 | - | $903.00 K(+196.6%) | $2.67 M(+41.1%) |
Dec 2013 | - | $304.40 K(-77.8%) | $1.89 M(+0.9%) |
Sep 2013 | $1.87 M(+12.9%) | $1.37 M(+1476.0%) | $1.87 M(+81.9%) |
Jun 2013 | - | $87.00 K(-31.3%) | $1.03 M(-17.3%) |
Mar 2013 | - | $126.60 K(-56.0%) | $1.24 M(-16.1%) |
Dec 2012 | - | $287.90 K(-45.5%) | $1.48 M(-10.9%) |
Sep 2012 | $1.66 M(-53.5%) | $528.00 K(+74.9%) | $1.66 M(-5.9%) |
Jun 2012 | - | $301.90 K(-17.2%) | $1.77 M(-23.9%) |
Mar 2012 | - | $364.60 K(-22.2%) | $2.32 M(-26.8%) |
Dec 2011 | - | $468.50 K(-25.9%) | $3.17 M(-11.2%) |
Sep 2011 | $3.57 M(+22.7%) | $632.20 K(-26.2%) | $3.57 M(-6.3%) |
Jun 2011 | - | $856.10 K(-29.6%) | $3.81 M(+4.6%) |
Mar 2011 | - | $1.22 M(+39.8%) | $3.65 M(+16.4%) |
Dec 2010 | - | $869.30 K(-0.4%) | $3.13 M(+6.9%) |
Sep 2010 | $2.91 M(+12.3%) | $872.60 K(+26.8%) | $2.93 M(+5.1%) |
Jun 2010 | - | $688.10 K(-1.9%) | $2.79 M(-3.9%) |
Mar 2010 | - | $701.70 K(+5.0%) | $2.90 M(+9.9%) |
Dec 2009 | - | $668.30 K(-8.4%) | $2.64 M(+1.8%) |
Sep 2009 | $2.59 M(-31.6%) | $729.90 K(-8.9%) | $2.59 M(-25.1%) |
Jun 2009 | - | $801.20 K(+81.6%) | $3.46 M(-7.6%) |
Mar 2009 | - | $441.10 K(-29.0%) | $3.75 M(+0.1%) |
Dec 2008 | - | $621.70 K(-61.1%) | $3.74 M(-1.9%) |
Sep 2008 | $3.79 M(+513.1%) | $1.60 M(+47.4%) | $3.81 M(+54.9%) |
Jun 2008 | - | $1.09 M(+149.0%) | $2.46 M(+54.8%) |
Mar 2008 | - | $436.10 K(-37.0%) | $1.59 M(+22.6%) |
Dec 2007 | - | $692.30 K(+178.3%) | $1.30 M(+110.0%) |
Sep 2007 | $618.20 K(+2324.3%) | $248.80 K(+16.3%) | $618.20 K(+64.8%) |
Jun 2007 | - | $214.00 K(+49.4%) | $375.10 K(+124.9%) |
Mar 2007 | - | $143.20 K(+1073.8%) | $166.80 K(+489.4%) |
Dec 2006 | - | $12.20 K(+114.0%) | $28.30 K(+11.0%) |
Sep 2006 | $25.50 K(-72.1%) | $5700.00(0.0%) | $25.50 K(+28.8%) |
Jun 2006 | - | $5700.00(+21.3%) | $19.80 K(+40.4%) |
Mar 2006 | - | $4700.00(-50.0%) | $14.10 K(+50.0%) |
Dec 2005 | - | $9400.00(>+9900.0%) | $9400.00(>+9900.0%) |
Sep 2005 | $91.50 K(>+9900.0%) | - | - |
Dec 2004 | - | $0.00 | $0.00 |
Sep 2004 | $0.00 | - | - |
FAQ
- What is Anavex Life Sciences annual SGA?
- What is the all time high annual SGA for Anavex Life Sciences?
- What is Anavex Life Sciences annual SGA year-on-year change?
- What is Anavex Life Sciences quarterly SGA?
- What is the all time high quarterly SGA for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly SGA year-on-year change?
- What is Anavex Life Sciences TTM SGA?
- What is the all time high TTM SGA for Anavex Life Sciences?
- What is Anavex Life Sciences TTM SGA year-on-year change?
What is Anavex Life Sciences annual SGA?
The current annual SGA of AVXL is $11.04 M
What is the all time high annual SGA for Anavex Life Sciences?
Anavex Life Sciences all-time high annual SGA is $13.07 M
What is Anavex Life Sciences annual SGA year-on-year change?
Over the past year, AVXL annual SGA has changed by -$1.00 M (-8.31%)
What is Anavex Life Sciences quarterly SGA?
The current quarterly SGA of AVXL is $2.78 M
What is the all time high quarterly SGA for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly SGA is $3.90 M
What is Anavex Life Sciences quarterly SGA year-on-year change?
Over the past year, AVXL quarterly SGA has changed by -$78.00 K (-2.73%)
What is Anavex Life Sciences TTM SGA?
The current TTM SGA of AVXL is -$1.27 B
What is the all time high TTM SGA for Anavex Life Sciences?
Anavex Life Sciences all-time high TTM SGA is -$106.00 K
What is Anavex Life Sciences TTM SGA year-on-year change?
Over the past year, AVXL TTM SGA has changed by -$1.29 B (-11846.08%)